Neurologic clinical trials - Ivy Brain Tumor Center: Phase 0+2 (ribociclib+ everolimus)

CONDITION(S): Brain Tumor, High Grade Glioma, Glioblastoma, Phase O, CNS Tumor - TRIAL: Ivy Brain Tumor Center: Phase 0+2 (ribociclib+ everolimus) - A Phase 0 /II Study of Ribociclib (LEE011) in combination with Everolimus in Preoperative Rb-Intact Recurrent High-Grade Glioma Patients Scheduled for Resection to Evaluate Central Nervous System (CNS) Penetration.

Drug

Ribociclib (LEE011) in combination with Everolimus

Trial Type

Interventional

Phase

Phase 0 + 2

Condition

Brain Tumor High Grade Glioma Glioblastoma Phase O CNS Tumor Tumor resection

Keywords

CNS Tumor | Phase O | Glioblastoma | High Grade Glioma | Brain Tumor | Ivy Brain Tumor Center